Excitotoxic insults to the optic nerve alter visual evoked potentials

Neuroscience

Volumn 123, Issue 2, 2004, Pages 441-449

  Soto, A ^a   Perez Samartin A L ^a   Etxebarria, E ^a   Matute, C ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

Excitotoxicity; Glutamate receptors; Kainate; Oligodendrocytes

Indexed keywords

APC; EXCITOTOXIN; KAINIC ACID; MYELIN BASIC PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANNULA; CONTROLLED STUDY; DEMYELINATION; EVALUATION; EVOKED VISUAL RESPONSE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; NERVE FIBER; NERVE FUNCTION; NEUROFILAMENT; NEUROTOXICITY; NONHUMAN; OLIGODENDROGLIA; OPTIC NERVE; OSMOTIC PUMP; PHOTOSTIMULATION; PRIORITY JOURNAL; RABBIT; VISUAL CORTEX;

EID: 0346787797     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2003.09.009     Document Type: Article

References (26)

1. Andersson T., Sidén A. An analysis of VEP components in optic neuritis. Electromyogr Clin Neurophysiol. 35:1995;77-85.
2. Arezzo J.C., Brosnan C.F., Schroeder C.E., Litwak M.S., Bornstein M.B. Electrophysiological analysis of factors involved in the primary demyelinating diseases the rabbit eye model system . Brain Res. 462:1988;286-300.
3. Barkhatova V.P., Zavalishin I.A., Askarova L.S., Shavratskii V.K., Demina E.G. Changes in neurotransmitters in multiple sclerosis. Neurosci Behav Physiol. 28:1998;341-344.
4. Brusa A., Jones S.J., Plant G.T. Long-term remyelination after optic neuritis. A. 2:(-year visual evoked potential and psycophysical serial study. Brain 124):2001;468-479.
5. García-Barcina J.M., Matute C. Expression of kainate-selective glutamate receptor subunits in glial cells of the adult bovine white matter. Eur J Neurosci. 8:1996;2379-2387.
6. García-Barcina J.M., Matute C. AMPA-selective glutamate receptor subunits in glial cells of the adult bovine white matter. Brain Res Mol Brain Res. 53:1998;270-276.
7. Gensert J.A., Goldman J.E. Endogenous progenitors remyelinate demyelinated axons in the adult CNS. Neuron. 19:1997;197-203.
8. Halliday AM (1993a) The comparative value of the different evoked potentials and other paraclinical tests in the diagnosis and prognosis of demyelinating disease. In: Evoked potentials in clinical testing (Halliday AM, ed), pp 467-488. Edinburgh: Churchill-Livingstone.
9. Halliday AM (1993b) The visual evoked potentials in the investigation of diseases of the optic nerve. In: Evoked potentials in clinical testing (Halliday AM, ed), pp 195-278. Edinburgh: Churchill-Livingstone.
10. Hodges-Savola C., Rogers S.D., Ghilardi J.R., Timm D.R., Mantyh P.W. Beta-adrenergic receptors regulate astrogliosis and cell proliferation in the central nervous system in vivo. Glia. 17:1996;52-62.
11. Matute C. Characteristics of acute and chronic kainate excitotoxic damage to the optic nerve. Proc Natl Acad Sci USA. 95:1998;10229-10234.
12. Matute C., Alberdi E., Domercq M., Pérez-Cerdá F., Pérez-Samartín A., Sánchez-Gómez M.V. The link between excitotoxic oligodendroglial death and demyelinating diseases. Trends Neurosci. 24:2001;224-230.
13. Matute C., Sánchez-Gómez M.V., Martínez- Millán L., Miledi R. Glutamate receptor-mediated toxicity in optic nerve oligodendrocytes. Proc Natl Acad Sci USA. 94:1997;8830-8835.
14. McDonald J.W., Althomsons S.P., Hyrc K.L., Choi D.W., Goldberg M.P. Oligodendrocytes from forebrain are highly vulnerable to AMPA/kainate receptor-mediated excitotoxicity. Nat Med. 4:1998;291-297.
15. Ozawa K., Suchanek G., Bretischopf H. Patterns of oligodendroglia pathology in multiple sclerosis. Brain. 117:1994;1311-1322.
16. Pitt D., Werner P., Raine C.S. Glutamate excitotoxicity in a model of multiple sclerosis. Nat Med. 6:2000;67-70.
17. Prineas JW, McDonald WI, Franklin RJM. (2002) Demyelinating diseases. In: Greenfield's neuropathology, Vol. 2 (Graham DI, Lantos PL, eds), pp 471-550. London, UK: Arnold Publisher.
18. Prineas J.W., Barnard R.O., Kwon E.E., Sharer L.R., Cho E.S. Multiple sclerosis remyelination of nascent lesions . Ann Neurol. 33:1993;137-151.
19. Smith T., Groom A., Zhu B., Turski L. Autoimmune encephalomyelitis ameliorated by AMPA antagonists. Nat Med. 6:2000;62-66.
20. Steinmann L. Multiple sclerosis a two-stage disease . Nat Immunol. 2:2001;762-764.
21. Stover J.F., Pleines U.E., Morganti-Kossmann M.C., Kossmann T., Lowitzsch K., Kempski O.S. Neurotransmitters in cerebrospinal fluid reflect pathological activity. Eur J Clin Invest. 27:1997;1038-1043.
22. Trapp B.D., Peterson J., Ransohoff R.M., Rudick R., Mork S., Bo L. Axonal transection in the lesions of multiple sclerosis. N Engl J Med. 338:1998;278-285.
23. Utzschneider D.A., Archer D.R., Kocsis J.D., Waxman S.G., Duncan I.D. Transplantation of glial cells enhances action potential conduction of amyelinated spinal cord axons in the myelin-deficient rat. Proc Natl Acad Sci USA. 91:1994;53-57.
24. Vaney D.I., Hughes A. The rabbit optic nerve fibre diameter spectrum, fibre count, and comparison with a retinal ganglion cell count . J Comp Neurol. 170:1976;241-251.
25. Werner P., Pitt D., Raine C. Multiple sclerosis altered glutamate homeostasis in lesions correlates with oligodendrocyte and axonal damage . Ann Neurol. 50:2001;169-180.
26. Yoshioka A., Bacskai B., Pleasure D. Pathophysiology of oligodendroglial excitotoxicity. J Neurosci Res. 46:1996;427-437.